Cloverleaf unlocks the power of real-world evidence in clinical and pharmaceutical research

Real-world evidence (RWE) from sources like health records, wearable devices and more is on the rise in clinical and pharmaceutical research. Cloverleaf, the leading clinical interoperability platform (please add this link on "the leading clinical interoperability platform" https://www.infor.com/resources/black-book-top-clinical-data-integration-engines), empowers you to tap into RWE’s full potential. With a proven global track record, Cloverleaf streamlines data sharing with research partners to facilitate rapid and efficient data connectivity

Find out the compelling advantages of RWE:

• Broader patient representation
• Larger sample sizes
• Long-term and real-life outcomes
• Cost-effectiveness
• Post-marketing surveillance
• Research flexibility and speed

Read the brochure now.